Resistance to platinum drugs is a significant challenge in cancer treatment. Strategies to manage resistance include using combination therapy approaches, where platinum drugs are paired with other agents to enhance their efficacy. Researchers are also investigating molecular mechanisms of resistance to develop novel drugs or treatment strategies that can bypass these mechanisms.
